Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Biology

Paleontology

Medicine

Internal Medicine

Pediatrics

Show all topics

DOI

10.1016/s0140-6736(22)02083-9

License

CC-BY

Other Formats

PDF